- Mobile site
- E-Newsletters
-
- News feed
- Find us on Twitter
@yorkpress
Follow us on Twitter
- Find us on Facebook
The Press, York
Like us on Facebook
‘If the treatment doesn’t work, they tell you to go home and enjoy the time you have.” (From York Press)
Get in touch: send your photos, videos, news & views by texting YORK to 80360 or send an email»
‘If the treatment doesn’t work, they tell you to go home and enjoy the time you have.”
9:42am Friday 20th April 2012 in Health & Wellbeing By Gavin Aitchison & Richard Catton
FAMILIES of child cancer victims have to spend hundreds of thousands of pounds on treatment abroad, because British care is not good enough, it has been claimed.
North Yorkshire families and national campaigners today called for a rethink on NHS care for young victims, to prevent families having to spend huge amounts of time and money flying to the United States or Germany for treatment.
John Inglis, father of York neuroblastoma victim Jamie, and Katie Clifford, mother of two-year-old Sadie Rose who has been fighting the condition most of her young life, led the calls for change.
Mrs Clifford, of Knaresborough, said she felt let down that the UK had no action plan for children with the disease.
She said: “When we were in America, we met a few families from Norway who have had everything, from treatment to living costs, paid for by the Norwegian government, and this makes us feel let down by our own.”
Mr Inglis said he hoped to organise a meeting in York for affected parents, and said he was looking to lobby on the fact that families were “having to put themselves through this”.
He said neuroblastoma affected about 100 new families a year, but said every family he knew would prefer treatment in the UK, and he now wanted to lobby the Government and NHS bosses to provide better care for victims who relapse.
He said: “Here, it is almost as if they have written children off. We know it is an aggresive cancer and the chances are not good. But in the US, kids live to their teens. Here, they hit relapse and it is not good. They give chemotherapy, but if the treatment does not work, they tell you to go home and enjoy the time you have.”
He praised the treatment in Germany and America, where he said antibodies and viruses had been developed to attack the cancer, and said it gave families more hope.
He said: “Kids can have a good quality of life. Jamie had a good quality of life, and maybe that treatment he had has bought him two years, so it was worth that £350,000.”
He said the Neuroblastoma Alliance was supporting 17 families, potentially at a cost of £500,000 each.
He said: “They have been very supportive and we are hoping to have a conference with the neuroblastoma alliance in May up here in York.”
John Rogers, secretary of a group of families affected by neuroblastoma and whose daughter, Stella, underwent treatment in Philadelphia at the same time as Jamie Inglis, also called on the Government to do more.
He said they should invest in research so breakthrough treatments could be developed here, should try to cut through red tape so promising treatments developed elsewhere could be made available more quickly in Britain, and should fund any British families in the meantime that had to travel abroad.
He said: “Even if we gave £100 million tomorrow, it would take years to do anything. The best chance you have got is making the treatments being developed abroad available here more quickly.
“We will not change things overnight – people will still have to get on planes. There is talk about making the German treatments available here, but it will take years. In the meantime, children are going to die.”
He said that 20 years ago, virtually nobody survived neuroblastoma, but now about two-thirds of children treated by the specialists in America lived for at least five years.
Mrs Clifford said: “Because neuroblastoma isn’t one of the most common forms of cancer, no one wants to fund research, and this is why we have to raise hundreds of thousands of pounds to get treatment abroad”.
Meanwhile, Mr Inglis said: “I think there is an ethos that because you have such an aggresive cancer and the prognosis is not good, they give up. It’s very disheartening. We know this cancer could beat Jamie in the end – but we will not go without a fight.”
Yesterday, The Press reported four year-old Thomas Cammack from Selby, had lost his battle with neuroblastoma on Wednesday.
Comments(7)
Daisy75
says...
5:51pm Fri 20 Apr 12
Birdni
says...
11:56pm Fri 20 Apr 12
Daisy75
says...
5:34pm Sat 21 Apr 12
When it comes to what the NHS offers/ doesn't, I'm sure there are trials going on here not on offer elsewhere in the world, equally though, the healthcare available in the US without health insurance is of far poorer quality than that available here, and such families are equally dependent on fundraising and pro bono work from medical staff.
FebruaryMckay
says...
2:29pm Sun 22 Apr 12
When my daughter initially relapsed she was given 3 rounds of salvage chemo (Irinotecan and Temozolomide) here in The UK. Even though this practically cleared her of disease it left her with absolutely no quality of life, so sick was she that I would not allow her to have any more.
Thankfully I was aware of many children being treated in Philadelphia and Memorial Sloane Kettering Cancer Centre in New York (mskcc). I will only speak for The Children's Hospital of Philadelphia (CHOP) because We as a family have no experience with mskcc.
The Philosophy at Chop is that they treat Neuroblastoma as a chronic disease. If you cannot cure a disease then surely this is the next best desirable option? Obviously for some children with unresponsive, rapidly progressing disease this is not an option and they will have sadly succumbed to Neuroblastoma before a plan could be formulated. For many others 'stable disease' can become a real option.
I believe the Neuroblastoma team at Chop consists of about 9 Neuroblastoma doctors, 2 nurse practitioners, 2 research nurses and a Neuroblastoma social worker.
My daughter's doctor is a highly respected Neuroblastoma expert, he is the Chief of Oncology at what is probably the best and largest hospital in The US, if not the world. He has an excellent relationship with our doctor here in England where their professional respect for each other is very clear. Hardly quackery.... The reason I say this is that my daughter's doctor at Chop has no idea about the financial cost of the treatment he prescribes- that is between the parent and their insurance company. He doesn't make clinical decisions based on money. He was also insistent that we see how my daughter responded to the initial salvage chemo given in The UK before we travelled.
I see so many children who have relapsed or refractory Neuroblastoma take part in clinical study after clinical study. These often consist of low dose chemo, inhibitors, vaccines, or immunotherapy. Again, the emphasis is on 'quality of life' as these children have already suffered (and subsequently failed) the worst cancer treatment protocol given to a person. Call these studies what you wish- treatments, trials or even experiments- they provide many children with years of life they would certainly not have if they lived here in The UK.
As a family we have experienced the healthcare on both the Sides of The Atlantic and while both systems have their problems, I know where I would like to be treated if I was a child with cancer- without a doubt!
Whereas I prefer science and advances in medicine over a magic wand, wouldn't it be great if a wand could be waved over SOME of the doctors in The Uk, magic them into being a little more forward thinking, realistic and less defeatist (could also use it to rustle up that trial that may be going on here but not on offer anywhere else in the world....).
john647
says...
3:15pm Sun 22 Apr 12
The staff on the oncology teams within the NHS from our experience are excellent and supportive, however it is the ethos and culture within the NHS at the higher levels that do not promote change and development into this and other orphan groups of paediatric cancers. Currently there is encouraging R&D across the world and advanced trials which show promising results! With further collaboration and resources being put into NB research then perhaps we are on the cusp of a curative approach!
Birdni
says...
11:39am Mon 23 Apr 12
ny. Of course they are trials and have no guarantee of success. But yesterday's Phase I/II trials are today's standard treatments. It is about selecting the best choice of therapy, for a particular type of disease as neuroblastoma can affect soft-tissue, bones and bone marrow. It is about being lucky enough to have the right type of disease to be able to enrol on the right trial at the right time. Germany were trying to cure relapsed neuroblastoma a decade ago with intensive relapse treatment. Sadly, most children still passed away, but some are alive and well and cancer-free today many years later. What neuroblastoma parent wouldn't want to keep trying if there's a chance, however small, that their child could still be cured? One such young man introduced himself at a conference in Germany recently. Diagnosed with neuroblastoma 20 years ago, twice relapsed, now free from cancer for more than a decade and studying to work in the department that treated him. Find me a similar story in the UK ... please.
lezyork1966 says...
10:13am Fri 20 Apr 12
It really is as simple as a doctor in country A copying the doctors treatment in country B if B has something that works, if there not doing that, you have to ask why.
By all means always look at all the options, but look below the glossy firstpage of hype, and see if figures exist, when you have to choose and choose once, then hard facts is what you need.